Biotechnology

Daily Stock Watch: Biotech Stock BLI Rises 20%

Berkeley Lights (NASDAQ: BLI) released Q3 earnings with record recurring revenues, leading the BLI share price to rise 20%.

IPO Outlook: BFAI, SNAL, ACRV

The IPOs to look out for this week include medicine development and AI specialist BullFrog AI, game developer Snail and biopharma outfit Acrivon Therapeutics.

Daily Stock Watch: Aurinia Pharmaceuticals Slashes Sales Forecast

Aurinia Pharmaceuticals (NASDAQ: AUPH) has seen its share price fall yet further as Q3 results included a cut in sales forecast. But is AUPH stock worth investing in?

Daily Stock Watch: ESSA Pharma Dips on Trial Suspension

Though ESSA Pharma Inc (NASDAQ: EPIX) saw its share price soar last week on strong pre-clinical news, a trial hiccup is giving investors jitters. But is EPIX stock a good investment?

IPO Outlook: MBLY, ASPI, INTS

The coming week's IPOs could include offerings from Mobileye Global (NASDAQ: MBLY), ASP Isotopes (NASDAQ: ASPI) and Intensity Therapeutics (NASDAQ: INTS)

Daily Stock Watch: IMUX Stock Tumbles on Placebo Performance

Immunic Inc (NASDAQ: IMUX) has lost three quarters of its share price after investors were left unimpressed with clinical trial data. But is IMUX stock a good investment?

IPO Outlook: ALPX, BMR, ASPI, INTS, PRME

The coming week's IPOs could include offerings from Alopexx (NASDAQ: ALPX), Beamr Imaging (NASDAQ: BMR), ASP Isotopes (NASDAQ: ASPI), Intensity Therapeutics (NASDAQ: INTS) and Prime Medicine (NASDAQ: PRME).

Daily Stock Watch: MIST Stock Falters Despite Trial Success

One stock heading lower at the start of this week is biopharma outfit Milestone Pharmaceuticals (NASDAQ: MIST). But is MIST stock a good investment?

IPO Outlook: ALPX, BMR, CTM

Some of the IPOs slated for the week ahead include Alopexx (NASDAQ: ALPX), Beamr Imaging (NASDAQ: BMR) and Castellum (NYSEAMERICAN: CTM).

Daily Stock Watch: PRVB Stock Buoyant Following Sanofi Deal

Having just signed a major deal with a top pharma player, Provention Bio (NASDAQ: PRVB) is attracting investors' attention. But is PRCB stock a good investment?

Should You Buy Wave Life Sciences Stock?

Wave Life Sciences is leading a new era of precision medicine in which rationally designed oligonucleotides are the key to delivering safer, more effective medicines.

Why Investing in Biopharma Could Boost Your Portfolio

Are biopharma stocks the missing secret ingredient for your portfolio? Read on to find out why investing in biopharma could leave you with sizeable returns if you play your cards right.

IPO Outlook: LRE, LBGJ, INTS, PRZO, YGF

Some of the IPOs slated for the week ahead include Lead Real Estate (NASDAQ: LRE), Li Bang International (NASDAQ: LBGJ), Intensity Therapeutics (NASDAQ: INTS), ParaZero Technologies (NASDAQ: PRZO) and YanGuFang International Group (NASDAQ: YGF).

Daily Stock Watch: VRAX Stock Climbs on Monkeypox Testing News

Virax Biolabs Group Ltd (NASDAQ: VRAX) is a heavy gainer on Tuesday morning after its new monkeypox rapid antigen test kits grabbed investors' attention. But is VRAX stock worth investigating?

Daily Stock Watch: Is NRBO Stock A Good Investment?

Neurobo Pharmaceuticals (NASDAQ: NRBO) has seen its share price climb on the back of a reverse stock split, but is NRBO stock a good investment?